Tara Berman, MD, MS

Dr. Tara Berman is a medical oncologist at Dana-Farber Cancer Institute, specializing in treating patients with GYN malignancies, as well as a Member of Faculty at Harvard Medical School. She serves on the Dana-Farber Clinical Faculty Council.  She is a recipient of the 2022 Gynecologic Oncology Group New Investigator Award and was a selected participant in the Society of Gynecologic Oncology Bridges Research Initiative, inaugural cohort. Prior to joining Dana-Farber, Dr. Berman helped establish the medical gynecologic oncology clinic at the Inova Schar Cancer Institute in Fairfax, VA. She was also a medical officer for the United States Food and Drug Administration on the Breast/Gyn Malignancies Team in the Office of Oncologic Disease at the Center for Drug Evaluation and Research (CDER) and served as the Integrative Oncology Liaison for CDER. Dr. Berman received her medical degree from the Sackler School of Medicine in Tel Aviv and Master of Science in Nutrition from Columbia University. She completed her internal medicine residency at Mount Sinai West in New York City and completed her Oncology Fellowship at the National Cancer Institute, National Institute of Health (NIH) in Bethesda, MD. Dr. Berman’s research interests are in integrative oncology, the tumor microbiome, and developing new treatment strategies for gynecologic cancers. She serves on the Board of the Society for Integrative Oncology (SIO).